Molecular imaging is the visualization, characterization and measurement of biological processes at the molecular and cellular level. In oncology, molecular imaging approaches can be directly applied as translational biomarkers of disease progression. In this article, selected imaging modalities are discussed with respect to this role. Recent studies focusing on emerging imaging biomarkers and new developments in the field are highlighted. Importantly, because ex vivo or tissue-based imaging now represents an important tool in the discovery and validation of oncology biomarkers, special attention is given to this resurgent field. © 2009 Elsevier Ltd. All rights reserved.
CITATION STYLE
van der Meel, R., Gallagher, W. M., Oliveira, S., O’Connor, A. E., Schiffelers, R. M., & Byrne, A. T. (2010, February). Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2009.12.003
Mendeley helps you to discover research relevant for your work.